Melanoma
-
Could the Moderna-Merck Melanoma Vaccine Win FDA Approval Within Two Years? What We Know
Intismeran met primary endpoints in phase 3, but FDA filing date remains unannounced as companies race toward potential 2027 approval.
-
Fulvic Acid and Cancer: What the 14-Hour Melanoma Study Actually Found
A viral reel cites a 2022 lab study on melanoma cells. Here is what it tested, what it found and what it…
-
Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk 42% in Late-Stage Trial
Discover how custom mRNA cancer vaccines train the immune system against tumor neoantigens to prevent melanoma recurrence compared to standard adjuvant therapy.
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
The numbers first: 1,137 patients, split two to one, all with melanoma that surgeons had already removed. On Wednesday, 19 August 2026,…
-
Jimmy Carter’s Melanoma Treatment Changed Cancer Care, Doctors Say
Rome, October 1 — The mechanics here are straightforward: immunotherapy, a breakthrough in cancer treatment, has generated significant revenue for biotechnology companies,…
-
Merck and Moderna Report Phase 3 Win for mRNA Melanoma Therapy Plus Keytruda
New York, August 20 — Merck and Moderna announced successful results from a late-stage clinical trial for an mRNA-based cancer vaccine targeting…
-
Sea Squirt Compound Shows Promise Against Melanoma Cells
NEW YORK, July 8 — 1%. That figure that matters: melanoma accounts for about 1% of all skin cancers, yet it causes…
-
Sea Squirt from Antarctic Depths Holds Promise for Melanoma Treatment
ANTARCTICA, July 8 — A marine organism discovered during a scientific expedition to Antarctica is now being studied as a potential new…
-
NHS urges Britons to check moles for ABCDE melanoma signs this summer
Britons with moles are being told to look for five specific changes this summer. The NHS posted a checklist on social media…
-
Pittsburgh Team Finds TPP1 Mutation Helps Melanoma Cells Keep Telomeres Long
PITTSBURGH — Scientists at the University of Pittsburgh School of Medicine have identified a crucial missing piece in the long-standing mystery of…
-
Tiny Antarctic creature may hold key to melanoma treatment
TAMPA, June 29 — The bottom line: a toxin from a tiny sea creature collected off Antarctica has already killed melanoma cells…
-
Antarctic sea creature toxin shows melanoma-killing potential in mouse study
A toxin harvested from a tiny sea creature collected off Antarctica has killed melanoma in mice without harming the mice. That fact…
-
USF researchers find Antarctic sea squirt compound kills melanoma in mice
TAMPA — Six weeks in Antarctic waters. Dives to 130 feet. Half-hour bottom times. And one compound that killed melanoma in mice…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992